meglumine and Experimental Neoplasms

meglumine has been researched along with Experimental Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, CE; Brady-Kalnay, SM; Clark, H; Darrah, RJ; Drumm, ML; Erokwu, BO; Flask, CA; Griswold, MA; Gu, Y; Hu, H; Johansen, M; Kavran, M; Li, M; Steinmetz, NF; Vincent, J; Yu, X; Zhang, Y1
Bessoud, B; Brillet, PY; Clement, O; Cuenod, CA; Frija, G; Gazeau, F; Kahn, E; Luciani, A; Olivier, JC; Siauve, N; Uchegbu, IF1
Akine, Y; Churei, H; Kanda, K; Kobayashi, T; Le Pechoux, C; Satoh, M; Tokita, N; Tokuuye, K1
Howes, LG; Morris, DL; Romani, R1
Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; McCormick, RI1
Braunschweiger, PG; Furmanski, P; Schiffer, L1
Braunschweiger, PG; Furmanski, P; Schiffer, LM1

Other Studies

7 other study(ies) available for meglumine and Experimental Neoplasms

ArticleYear
Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting.
    Scientific reports, 2019, 12-27, Volume: 9, Issue:1

    Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds

2019
Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes.
    Radiology, 2004, Volume: 231, Issue:1

    Topics: Animals; Biomarkers, Tumor; Brain; Contrast Media; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Liver; Magnetic Resonance Imaging; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds; Polyethylene Glycols; Radiographic Image Enhancement; Receptors, Cell Surface; Surface-Active Agents; Time Factors; Tissue Distribution

2004
Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.
    Japanese journal of cancer research : Gann, 1993, Volume: 84, Issue:8

    Topics: Animals; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Infusions, Intra-Arterial; Male; Meglumine; Neoplasms, Experimental; Neutron Capture Therapy; Organometallic Compounds; Pentetic Acid; Rabbits

1993
Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro.
    The Australian and New Zealand journal of surgery, 1996, Volume: 66, Issue:4

    Topics: Administration, Oral; Analysis of Variance; Animals; Cell Division; Colorectal Neoplasms; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Receptors, Cholecystokinin; Tumor Cells, Cultured

1996
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer.
    Urological research, 2002, Volume: 30, Issue:1

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Meglumine; Neoplasms, Experimental; Organ Culture Techniques; Rats; Rats, Wistar; Urinary Bladder Neoplasms

2002
The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
    Magnetic resonance imaging, 1986, Volume: 4, Issue:4

    Topics: Animals; Chromium Radioisotopes; Contrast Media; Edetic Acid; Extracellular Space; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid

1986
1H-NMR relaxation times and water compartmentalization in experimental tumor models.
    Magnetic resonance imaging, 1986, Volume: 4, Issue:4

    Topics: Animals; Body Fluid Compartments; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid

1986